Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Dahham Alsoud Dirk Jan A R Moes Zhigang Wang Rani Soenen Zohra Layegh Murray L Barclay Tomoyuki Mizuno Iris K Minichmayr Ron J Keizer Sebastian Georg Wicha Gerrit J Wolbink Jo Lydie Wilfried Lambert Severine Vermeire Annick de Vries Konstantinos Papamichael Núria Padullés-Zamora Erwin Dreesen

Published in: Therapeutic drug monitoring (2024)

Successful implementation of TDM for infliximab necessitates interdisciplinary collaboration among clinicians, hospital pharmacists, and (quantitative) clinical pharmacologists to ensure an efficient research trajectory.

Keyphrases

healthcare
primary care
ulcerative colitis
palliative care
quality improvement
high resolution
emergency department
mass spectrometry